Vident Investment Advisory’s Avanos Medical AVNS Stock Holding History

Vident Investment Advisory’s Portfolio AVNS Stock Details AVNS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q1	–	Sell	-49,406	Closed	-$2.21M	–	713
2018 Q4	$2.21M	Sell	49,406 -6,935	-12%	-$363K	0.12%	216
2018 Q3	$3.86M	Buy	+56,341	New	+$3.63M	0.15%	136
2018 Q2	–	Sell	-70,602	Closed	-$3.38M	–	906
2018 Q1	$3.38M	Buy	70,602 +2,605	+4%	+$124K	0.14%	178
2017 Q4	$3.14M	Buy	67,997 +4,147	+6%	+$191K	0.14%	183
2017 Q3	$2.88M	Sell	63,850 -1,177	-2%	-$50.2K	0.16%	165
2017 Q2	$2.55M	Buy	65,027 +1,012	+2%	+$38.2K	0.21%	158
2017 Q1	$2.44M	Sell	64,015 -6,344	-9%	-$247K	0.24%	172
2016 Q4	$2.6M	Buy	70,359 +2,919	+4%	+$104K	0.32%	123
2016 Q3	$2.34M	Buy	+67,440	New	+$2.36M	0.31%	130

Other funds holding AVNS

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

CIP

Champlain Investment Partners Burlington, Vermont $7.88B AUM 6.82% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Victory Capital Management San Antonio, Texas $156B AUM 27.51% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

PIM

Paradice Investment Management Denver, Colorado $532M AUM 29.6% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Vident Investment Advisory's AVNS Position: Q1 2019 in Review

Vident Investment Advisory sold out of Avanos Medical (AVNS) in Q1 2019, closing a stake of 49,406 shares — an estimated $2.21M sold.

Vident Investment Advisory first reported a position in AVNS in Q3 2016 and held it in 9 quarters. The position peaked at $3.86M in Q3 2018. 338 funds tracked by Wall St. Rank hold AVNS as of Q1 2019.

Vident Investment Advisory reported no remaining Avanos Medical position as of Q1 2019 after selling out during the quarter.
Vident Investment Advisory sold 49,406 Avanos Medical shares in Q1 2019, an estimated $2.21M.
Vident Investment Advisory first reported a position in Avanos Medical in Q3 2016 and held it in 9 quarters.
Vident Investment Advisory's Avanos Medical position peaked at $3.86M in Q3 2018.
338 funds tracked by Wall St. Rank held Avanos Medical as of Q1 2019.

Based on Vident Investment Advisory's 13F filing for Q1 2019, filed 8 May 2019.